|
|
|
|
PRESS RELEASE |
||
|
|
MedChannels Cross-Licenses Technology with ApotheTechLAS VEGAS, NV, Jan. 04, 2006 /PRNewswire-FirstCall/ -- MedChannels, a state of Ohio limited liability corporation, has entered into a cross-promotional and private labeling agreement with ApotheTech International for automated medication dispensing products. The products will be launched under MedChannels' StatMed line. Specific terms of the cross-promotional and product licensing deal were not disclosed, although they include a combination of paid upfront fees and a percentage of sales as royalty. |
|
|
|
"I am very pleased, on both personal and professional levels, that we have been able to reach an agreement with ApotheTech on their industry-leading dispensing technology", said Martin James, President of MedChannels. "Although they have hit some rough times in terms of install base, my direct involvement with the development of their core hardware provides me with an insiders understanding of their underlying technology, which continues to be among the best in the industry. ApotheTech, in turn, will have unparalleled access to our knowledge-driven software products. I see this agreement as a key step in allowing both companies to achieve their fullest potential in their respective, but distinct, markets." |
|
|
|
Mr. James continued, "This is the first of multiple licensing agreements that MedChannels is in the process of finalizing and we foresee additional products coming on board in the immediate future that will enable MedChannels to offer a breadth of products and services unmatched in the clinical research industry." |
|
|
|
MedChannels is a leading provider of life science development and commercialization services and has regional distribution hubs in Columbus, Ohio and San Antonio, Texas with headquarters in Las Vegas, NV. Its principal activities are to provide integrated product development and commercial enrichment solutions to the pharmaceutical, biotechnology and medical device industries. The Group operates in three business segments, namely Product Development, Commercialization Services and the Informatics group. The Product Development group is primarily responsible for all phases of pre-clinical and clinical research. The Commercialization Services group is primarily responsible for sales force deployment and strategic marketing services including healthcare policy research and consulting services. The Informatics group is primarily responsible for providing market research solutions and strategic analyses to support healthcare decisions. |
|
|
|
* * * * * * * * * * * * * Statements in this release concerning expectations for the future are forward-looking statements. A variety of known and unknown risks, uncertainties and other factors could cause actual results, performance and expectations to differ materially from anticipated results, performance or expectations. These risks, uncertainties and other factors are discussed in the company's annual report and other documents filed from time to time with the appropriate regulatory agency. http://tbutton.prnewswire.com/prn/b1690X77317545 SOURCE: MedChannels, Inc. Web site: http: //www.medchannels.com CONTACT: John Davidson, Investor Relations of MedChannels, Inc., +1-614-730-1345 * * * * * * * * * * * * * |
|